Pharmarise Holdings Corporation (TYO:2796)

Revenue by Segment

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Medical Mall Management	505.00M	511.00M	506.00M	505.00M	503.00M
Other	986.00M	1.06B	834.00M	779.00M	764.00M
Dispensing Pharmacy	59.33B	52.63B	44.18B	42.33B	42.04B
Storage and Management of Medical Documents	647.00M	609.00M	664.00M	646.00M	699.00M
Drug/Convenience Store	8.04B	8.70B	8.28B	7.77B	7.60B
Total	69.51B	63.51B	54.47B	52.03B	51.61B

Revenue by Geography

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Japan	69.51B	63.51B	54.47B	52.03B	51.61B
Total	69.51B	63.51B	54.47B	52.03B	51.61B

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error